EFAVALEUKIN ALFA IS A NOVEL IL-2 MUTEIN THAT SELECTIVELY EXPANDS REGULATORY T CELLS: PHASE 1 RESULTS AND RATIONALE FOR PHASE 2 CLINICAL INVESTIGATION IN ULCERATIVE COLITIS

Farshid Firoozbakht  ¹     Nadia Tchao  ²     Nandita Sarkar  ²     Kevin Gorski  ²     Xuguang Hu  ²     Ingrid Rauter  ³     Claudia Pena Rossi  ^3    
1 Amgen Inc., Thousand Oaks, United States
² Amgen Inc., South San Francisco, United States
³ Amgen Inc., Zug, Switzerland

Topic
IBD, Nurses

Session
Old and new molecules in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)